Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T19:07:57.262Z.
Calculation as of: 2026-10-06T19:07:57.262Z.
Quote observation: 2026-10-06T19:05:13.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 651b3973db42e019715e3a8a4e975a06fcddd3d3dc4e12dda44c0d1ac22a80ea
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Quantum BioPharma Ltd.
Market Cap
$20.99M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$22.09M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$21.90M
Operating Cash Flow Yield
14.98%
TTM Avg
7.71%
3Y Avg
27.75%
5Y Avg
27.75%
Market Cap
$19.79M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$20.22M
Operating Cash Flow Yield
N/A
TTM Avg
0.55%
3Y Avg
0.55%
5Y Avg
0.55%
Market Cap
$23.09M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$23.15M
Operating Cash Flow Yield
13.48%
TTM Avg
9.88%
3Y Avg
29.38%
5Y Avg
84.78%
Market Cap
$18.41M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quantum BioPharma Ltd. (QNTM) | $20.99M | N/A | N/A | N/A | N/A |
| Modular Medical, Inc. (MODD)vs › | $22.09M | N/A | N/A | N/A | N/A |
| Aytu BioPharma, Inc. (AYTU)vs › | $21.90M | 14.98% | 7.71% | 27.75% | 27.75% |
| P3 Health Partners Inc. (PIII)vs › | $19.79M | N/A | N/A | N/A | N/A |
| NextCure, Inc. (NXTC)vs › | $20.22M | N/A | 0.55% | 0.55% | 0.55% |
| LeonaBio, Inc. (LONA)vs › | $22.24M | N/A | N/A | N/A | N/A |
| Rein Therapeutics Inc. (RNTX)vs › | $23.09M | N/A | N/A | N/A | N/A |
| TherapeuticsMD, Inc. (TXMD)vs › | $23.15M | 13.48% | 9.88% | 29.38% | 84.78% |
| Actuate Therapeutics Inc (ACTU)vs › | $18.41M | N/A | N/A | N/A | N/A |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.62M | N/A | 484.89% | 365.86% | 365.86% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
